Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viatris Inc.

10.17
+0.07000.69%
Post-market: 10.02-0.1516-1.49%19:55 EDT
Volume:5.51M
Turnover:55.91M
Market Cap:11.86B
PE:-3.48
High:10.20
Open:10.09
Low:10.07
Close:10.10
52wk High:13.55
52wk Low:6.85
Shares:1.17B
Float Shares:1.16B
Volume Ratio:0.74
T/O Rate:0.48%
Dividend:0.48
Dividend Rate:4.72%
EPS(TTM):-2.9198
EPS(LYR):-0.5315
ROE:-19.77%
ROA:2.30%
PB:0.76
PE(LYR):-19.14

Loading ...

Viatris Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 08

Viatris Inc. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
Jul 02

Viatris Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
Jun 28

Viatris Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jun 27

Viatris Inc. Announces Positive Results from Phase 3 VEGA-3 Trial for Presbyopia Treatment with MR-141

Reuters
·
Jun 26

Viatris Inc. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
Jun 25

Viatris Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Jun 21

BRIEF-EMA's CHMP Re-Examines Rejection Of Kisunla For Early Alzheimer’S Treatment

Reuters
·
Jun 20

Viatris Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
Jun 18

Viatris Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jun 13

Viatris Inc. to Report Second Quarter 2025 Financial Results

Reuters
·
Jun 13

Viatris Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Jun 10

Viatris Initiated at Neutral by Goldman Sachs

Dow Jones
·
Jun 06

Viatris Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Jun 06

Viatris Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 05

Viatris Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 03

BRIEF-Viatris Announces Positive Top-Line Results From Phase 3 Lynx-2 Trial Of Mr-142 In Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions

Reuters
·
Jun 02

Viatris Inc. Announces Breakthrough Phase 3 Trial Results for MR-142, Pioneering Treatment for Night Driving Impairment in Keratorefractive Patients

Reuters
·
Jun 02

Viatris Inc. Stock Climbs 2.8%, Outperforms Market

Dow Jones
·
May 30

Viatris Inc. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
May 28